This event has ended. Showing historical data.

$6.69K
1
1

1 market tracked

No data available
| Market | Platform | Price |
|---|---|---|
![]() | Poly | 0% |
$6.69K
1
1
Trader mode: Actionable analysis for identifying opportunities and edge
As of market creation, CRISPR Therapeutics is estimated to release earnings on February 11, 2026. The Street consensus estimate for CRISPR Therapeutics's GAAP EPS for the relevant quarter is $-1.17 as of market creation. This market will resolve to "Yes" if CRISPR Therapeutics reports GAAP EPS greater than $-1.17 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings
AI-generated analysis based on market data. Not financial advice.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/RlbRTZ" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="Will CRISPR Therapeutics (CRSP) beat quarterly earnings?"></iframe>